These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8458471)

  • 1. The ascites in the ovarian hyperstimulation syndrome does not originate from the ovary.
    Yarali H; Fleige-Zahradka BG; Yuen BH; McComb PF
    Fertil Steril; 1993 Mar; 59(3):657-61. PubMed ID: 8458471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic state and the role of angiotensin II in ovarian hyperstimulation syndrome in the rabbit.
    Teruel MJ; Carbonell LF; Llanos MC; Parrilla JJ; Abad L; Hernandez I
    Fertil Steril; 2002 Jun; 77(6):1256-60. PubMed ID: 12057737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of intravenous immunoglobulin in the prevention of severe ovarian hyperstimulation syndrome.
    Orvieto R; Achiron A; Margalit R; Ben-Rafael Z
    J Assist Reprod Genet; 1998 Jan; 15(1):46-9. PubMed ID: 9493066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of angiotensin converting enzyme inhibitor cilazapril and angiotensin II antagonist saralasin in ovarian hyperstimulation syndrome in the rabbit.
    Sahin Y; Kontaş O; Müderris II; Cankurtaran M
    Gynecol Endocrinol; 1997 Aug; 11(4):231-6. PubMed ID: 9272418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of letrozole on moderate and severe early-onset ovarian hyperstimulation syndrome in high-risk women: a prospective randomized trial.
    Mai Q; Hu X; Yang G; Luo Y; Huang K; Yuan Y; Zhou C
    Am J Obstet Gynecol; 2017 Jan; 216(1):42.e1-42.e10. PubMed ID: 27555316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pentoxifylline in the prevention of ovarian hyperstimulation syndrome in a rabbit model.
    Serin IS; Ozçelik B; Bekyurek T; Ozturk F; Koc N; Sahin Y
    Gynecol Endocrinol; 2002 Oct; 16(5):355-9. PubMed ID: 12587528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound and hematological changes during early luteal phase in women at high risk for developing ovarian hyperstimulation syndrome.
    Lainas GT; Lainas TG; Venetis CA; Sfontouris IA; Zorzovilis IZ; Alexopoulou E; Tarlatzis BC; Kolibianakis EM
    Ultrasound Obstet Gynecol; 2018 Jan; 51(1):126-133. PubMed ID: 29105961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Ovarian Hyperstimulation Syndrome.
    Blumenfeld Z
    Vitam Horm; 2018; 107():423-451. PubMed ID: 29544639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased angiotensin II in ascites during severe ovarian hyperstimulation syndrome: role of early pregnancy and ovarian gonadotropin stimulation.
    Delbaere A; Bergmann PJ; Gervy-Decoster C; Deschodt-Lanckman M; de Maertelaer V; Staroukine M; Camus M; Englert Y
    Fertil Steril; 1997 Jun; 67(6):1038-45. PubMed ID: 9176441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of ovarian kinin-kallikrein system in the pathophysiology of ovarian hyperstimulation syndrome: studies in a rat model.
    Ujioka T; Matsuura K; Tanaka N; Okamura H
    Hum Reprod; 1998 Nov; 13(11):3009-15. PubMed ID: 9853847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of enalapril in the prevention of ovarian hyperstimulation syndrome: a rabbit model.
    Gul TG; Posaci C; Caliskan S
    Hum Reprod; 2001 Nov; 16(11):2253-7. PubMed ID: 11679499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG.
    Seyhan A; Ata B; Polat M; Son WY; Yarali H; Dahan MH
    Hum Reprod; 2013 Sep; 28(9):2522-8. PubMed ID: 23633553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome.
    Rizk B; Aboulghar M; Smitz J; Ron-El R
    Hum Reprod Update; 1997; 3(3):255-66. PubMed ID: 9322101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe ovarian hyperstimulation syndrome modifies early maternal serum beta-human chorionic gonadotropin kinetics, but obstetrical and neonatal outcomes are not impacted.
    Choux C; Barberet J; Ginod P; Cottenet J; Bruno C; Benzénine E; Sagot P; Fauque P
    Fertil Steril; 2017 Oct; 108(4):650-658.e2. PubMed ID: 28911926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo intrabursal administration of bioactive lipid sphingosine-1-phosphate enhances vascular integrity in a rat model of ovarian hyperstimulation syndrome.
    Di Pietro M; Pascuali N; Scotti L; Irusta G; Bas D; May M; Tesone M; Abramovich D; Parborell F
    Mol Hum Reprod; 2017 Jun; 23(6):417-427. PubMed ID: 28379469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II immunoreactivity is elevated in ascites during severe ovarian hyperstimulation syndrome: implications for pathophysiology and clinical management.
    Delbaere A; Bergmann PJ; Gervy-Decoster C; Staroukine M; Englert Y
    Fertil Steril; 1994 Oct; 62(4):731-7. PubMed ID: 7926081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy and neonatal outcomes following luteal GnRH antagonist administration in patients with severe early OHSS.
    Lainas GT; Kolibianakis EM; Sfontouris IA; Zorzovilis IZ; Petsas GK; Lainas TG; Tarlatzis BC
    Hum Reprod; 2013 Jul; 28(7):1929-42. PubMed ID: 23624582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of a gonadotropin-releasing hormone agonist affects corpus luteum vascular stability and development and induces luteal apoptosis in a rat model of ovarian hyperstimulation syndrome.
    Scotti L; Irusta G; Abramovich D; Tesone M; Parborell F
    Mol Cell Endocrinol; 2011 Mar; 335(2):116-25. PubMed ID: 21238536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive ventilation for the treatment of acute respiratory failure following ovarian hyperstimulation syndrome: report of two cases and a brief review of the literature.
    Barlascini C; Piroddi MG; Perazzo A; Senarega R; Santo M; Nicolini A
    Pneumologia; 2015; 64(2):30-4. PubMed ID: 26506672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.